Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Ways to improve your budget mid month focus on reallocating surplus, trimming unnecessary expenses, and reinforcing savings to keep your finances on track.
24,575 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
H&R Block’s Q3 results set the tone for block (hrb) 2026 earnings. This guide breaks down the numbers, strategy, and ...
Costco’s iconic $1.50 hot dog combo endures as inflation bites elsewhere. Meanwhile, retirees face a long-running tax...
As Heico reports Q2 2026 results, investors want to know if margins hold and growth remains intact. This article brea...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
A major investor sold a substantial stake in an Ethereum ETF, pulling out nearly $19 million in one trade. The move r...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
AGNC Investment's dividend yield may catch your eye, but a high number isn’t the whole story. This guide breaks down ...
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
Nvidia and Broadcom sit at the heart of AI infrastructure. This guide breaks down which growth stock better fits diff...
As 2026 unfolds, investors are weighing which bank stocks offer durable growth and solid risk controls. This guide br...